Effect of Curcumin on chronic gastritis related to helicobacter pylori
Not Applicable
- Conditions
- Chronic Gastritis.Chronic gastritis, unspecified
- Registration Number
- IRCT2016012826238N1
- Lead Sponsor
- Ilam University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Age between 18 to 65 years? confirm of chronic gastritis according to histopathologic assay? presence of abdominal symptoms related to chronic gastritis. Exclusion criteria: recent use of antibiotics in the last 6 months? pregnancy? lactation? recent surgical procedures? alcohol? systemic diseases like coronary artery disease? diabetes? collagen vascular and central nervous system? age <18 years and above 70 years.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Malondialdehyde. Timepoint: Initial and after 8 weeks. Method of measurement: Randox Kit.;Total Antioxidant Capacity. Timepoint: Initial and after 8 weeks. Method of measurement: Randox Kit.;Glutathione peroxidase. Timepoint: Initial and after 8 weeks. Method of measurement: Randox Kit.;Prostaglandin E2. Timepoint: Initial and after 8 weeks. Method of measurement: RAI.;Chronic Gastritis. Timepoint: Initial and after 8 weeks. Method of measurement: Histology.;Endoscopic Inflammation Score. Timepoint: Initial and after 8 weeks. Method of measurement: Endoscopy.;DNA Oxidative Damage. Timepoint: Initial and after 8 weeks. Method of measurement: DNA Oxidative Damage Kit.
- Secondary Outcome Measures
Name Time Method